<DOC>
	<DOC>NCT02503527</DOC>
	<brief_summary>The purpose of this study is to determine the efficacy and safety of a diabetes-specific tube feed in comparison to an isocaloric, isonitrogenous standard enteral formula in critically ill patients receiving insulin treatment for blood glucose management.</brief_summary>
	<brief_title>Efficacy and Safety Study of a Low-carbohydrate Tube Feed in Critically Ill Patients Under Insulin Therapy</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Patients with spontaneous aneurysmal subarachnoid hemorrhage (SAH) defined according to Hunt and Hess scale grade HH5 Requiring mechanical ventilation in the ICU at the time of enrolment Enteral nutrition (EN) in the ICU at time of enrolment If enrolment on day 3 of ICU stay, EN equal to or larger than 80% of total calories in case of supplementary parenteral nutrition (PN) with anticipated 100% EN as of day 4 to 8 of ICU stay If enrolment on day 4 of ICU stay, 100% EN planned for at least 5 days from the time of enrolment Patients expected to stay in the ICU for at least 5 days following enrolment Age 18 75 years Glycemic control with intravenous insulin therapy to maintain a target glucose range between 110 mg/dL and 150 mg/dL (6.1 and 8.3 mmol/l) Informed consent according to local regulations for decisionally impaired subjects Patients with septic shock at time of enrolment Participation in a clinical trial with any investigational product within 4 weeks before study Patients requiring a fibre free diet Total or supplementary parenteral nutrition (&gt; 20% of total calories) Known or suspected intolerance or allergy to any component of the study product(s), e.g. galactosemia Gastrectomy Postpyloric nutrition Any clinical condition not allowing enteral nutrition (e.g. emesis, severe reflux, severe diarrhea) Known severe heart failure (NYHA class 4) Liver insufficiency / failure (male: ALAT &gt; 150 U/l; female: ALAT &gt; 120 U/l) Acute kidney failure (blood creatinine &gt; 2.5 mg/dl) Body Mass Index &lt; 18 or &gt; 35 kg/mÂ² Known or suspicion of drug abuse Pregnant or breast feeding women Patients with diabetes mellitus type I Exclusion After Enrolment (Withdrawal of Subjects) Start of PN with more than 20% of total given energy amount/ day Insulin infusion stopped unexpectedly for &gt; 12h for nonnutritional reasons Discharge from ICU Intolerable AEs Major protocol violation Withdrawal of informed consent Discontinuation of study treatment for other reasons</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Enteral nutrition</keyword>
	<keyword>Tube feeding</keyword>
	<keyword>Diet, carbohydrate-restricted</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Aneurysmal Subarachnoid Hemorrhage</keyword>
	<keyword>Blood glucose</keyword>
	<keyword>Insulin</keyword>
</DOC>